Skip to main content

Commissioning and the NHS

In all the discussions about the NHS it does appear that one thing is clear. We need to avoid the NHS being subject to EU Competition Law. This is the argument I have been putting. The danger is that commissioners are forced to accept tenders that they don't want to accept because of external pressure. It is that key distinction that changes the system from as it has been described as an internal market to an external market.

I do think progress is being made on this issue. However, cast iron certainty is needed for the bill to progress (which in part is why it is currently parked in a siding).

Comments

paulleake said…
The repeated response from ministers is that competition law (EU or otherwise) is not being extended to health, which seems a red herring.

Is there any clarity at all on whether changes to the way health is commissioned would move it within the scope of competition law _as it now stands_?

Popular posts from this blog

Its the long genes that stop working

People who read my blog will be aware that I have for some time argued that most (if not all) diseases of aging are caused by cells not being able to produce enough of the right proteins. What happens is that certain genes stop functioning because of a metabolic imbalance. I was, however, mystified as to why it was always particular genes that stopped working. Recently, however, there have been three papers produced: Aging is associated with a systemic length-associated transcriptome imbalance Age- or lifestyle-induced accumulation of genotoxicity is associated with a generalized shutdown of long gene transcription and Gene Size Matters: An Analysis of Gene Length in the Human Genome From these it is obvious to see that the genes that stop working are the longer ones. To me it is therefore obvious that if there is a shortage of nuclear Acetyl-CoA then it would mean that the probability of longer Genes being transcribed would be reduced to a greater extent than shorter ones.